2022: Two-year Impact Factor: 4.4
Scopus Journal Metrics
CiteScore (2022): 5.3
SJR(2022): 0.78
Open Access

Health Promot Perspect. 2019;9(3): 214-222. doi: 10.15171/hpp.2019.30
PMID: 31508342        PMCID: PMC6717928

Original Article

Do drug package inserts meet the rules and regulations of Iran’s Food and Drug Administration in terms of informing patients?

Tahereh Eteraf-Oskouei 1 ORCID, Saeid Abdollahpour 1 ORCID, Moslem Najafi 1 ORCID, Vahideh Zarea Gavgani 2,3 *

Cited by CrossRef: 4

1- Zheng Y, Tang Y, Tseng H, Chang T, Li L, Chen P, Tang Y, Lin X, Chen X, Tang K. Evaluation of quality and readability of over-the-counter medication package inserts. Research in Social and Administrative Pharmacy. 2022;18(9):3560 [Crossref]
2- Nualdaisri P, Corlett S, Krska J. Provision and Need for Medicine Information in Asia and Africa: A Scoping Review of the Literature. Drug Saf. 2021;44(4):421 [Crossref]
3- Anantharamu T, Narain N, Mathur A, Roy P, Gupta A. Package inserts: Are they present to guide our patients?. Med J DY Patil Vidyapeeth. 2022;0(0):0 [Crossref]
4- Marques L, Vasconcelos R, Baldoni A, Pestana A, Chequer F. Cardiovascular drug labeling: Do they have information on necessary precautions for older people?. Geriatr Gerontol Aging. 2020;14(3):196 [Crossref]

Indexing and Abstracting

2-year Impact Factor: 4.4


     Linked in Profile

   Academia Profile

Officially associated with The Iranian Health Education & Promotion Association  

Publication Advantages

Free of charge publication

Open access 

Fast and constructive peer review

Easy and fast online submission